Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 08:47:55 28/02/2017 +04 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.71M 2.52M 2.31M 4.34M 297M 4.4M 29.87M 11.67M 146M 11.56M 11.31M 504M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.19M 2.96M 2.72M 5.11M 349M 5.19M 35.19M 13.75M 172M 13.62M 13.33M 594M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+408.41%+629.49% 40.23B
-0.27%+4.45%+9.93%+66.92% 36.23B
+0.35%+0.87%+3.60%-8.81% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+31.97%+143.53% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%+0.76%+8.50% 13.12B
-2.68%-2.49%-15.00%-31.68% 12.7B
Average +10.20%+10.75%+54.97%+107.37% 24.53B
Weighted average by Cap. +0.48%+0.91%+75.32%+136.64%

Financials

2017 2018
Net sales 16.01K 14.06K 13.08K 12K 22.55K 1.54M 22.89K 155K 60.67K 758K 60.1K 58.81K 2.62M 124 108.91 101.28 92.94 174.63 11.94K 177.32 1.2K 469.89 5.87K 465.5 455.46 20.3K
Net income -481K -422K -393K -360K -677K -46.32M -688K -4.66M -1.82M -22.77M -1.81M -1.77M -78.73M -976K -857K -797K -731K -1.37M -93.95M -1.4M -9.46M -3.7M -46.19M -3.66M -3.58M -160M
Net Debt 497K 436K 406K 372K 700K 47.84M 710K 4.82M 1.88M 23.52M 1.86M 1.82M 81.31M 548K 482K 448K 411K 772K 52.8M 784K 5.32M 2.08M 25.96M 2.06M 2.01M 89.76M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-